☆ 4.7 Letter

Sustained responses after anti-CD38 treatment with daratumumab in two patients with refractory systemic lupus erythematosus

ANNALS OF THE RHEUMATIC DISEASES (2023)

Journal

ANNALS OF THE RHEUMATIC DISEASES

Volume -, Issue -, Pages -

Publisher

BMJ PUBLISHING GROUP

DOI: 10.1136/ard-2023-224152

Keywords

Systemic Lupus Erythematosus; Lupus Erythematosus; Systemic; Biological Therapy

Categories

Rheumatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.